Related Experiment Video
Updated: Jul 5, 2026

Establishment and Evaluation of a Risk Prediction Model for Pathological Escalation of Gastric Low-Grade Intraepithelial Neoplasia
Published on: February 16, 2024
Non-invasive tests in gastric diseases
1Section of Gastroenterology, Department of Clinical Sciences, University of Parma, Italy. francesco.dimario@unipr.it
Serological biomarkers like pepsinogens and gastrin can identify individuals at risk for gastric inflammation and atrophy, aiding early detection of gastric cancer precursors.
Area of Science:
- Gastroenterology
- Oncology
- Biomarker Discovery
Background:
- Gastric cancer, despite decreasing incidence, is a major cause of cancer mortality.
- Early diagnosis is challenging due to insidious development and advanced-stage presentation.
- Reliable non-invasive biomarkers for early gastric neoplasia detection are lacking.
Purpose of the Study:
- To review serological biomarkers for detecting gastric mucosa alterations.
- To analyze clinical studies on serological markers for gastric cancer risk assessment.
Main Methods:
- Review of existing literature on serological parameters.
- Analysis of biomarkers including serum pepsinogens I and II, gastrin-17, cytokines, and antibodies.
- Correlation of serological levels with gastric atrophy and inflammation.
Main Results:
- Low pepsinogen I and PGI/PGII ratio with high gastrin-17 indicate corpus atrophic gastritis.
- Low gastrin-17 suggests antral atrophic gastritis.
- Plasmatic ghrelin levels correlate with corpus atrophy.
- Anti-Helicobacter pylori IgG, CagA antibodies, and PGII detect gastric inflammation.
Conclusions:
- Serological parameters can identify individuals at risk for gastric inflammation and atrophy.
- These markers may help select subjects for further investigation of gastric neoplasia.
More Related Videos
Related Concept Videos
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Serum Laboratory Studies, Stool Test, Breath Test
Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and solid...
Endoscopic Procedures I: Esophagogastroduodenoscopy
During an EGD, the endoscope can be used to:
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...

![Assessment of Gastric Emptying in Non-obese Diabetic Mice Using a [13C]-octanoic Acid Breath Test](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F50301.jpg&w=3840&q=50)